Integra LifeSciences (NSDQ:IART) shares are under pressure this morning after the medical device maker reported its second-quarter results and lowered its outlook for the rest of the year. Plainsboro, N.J.-based Integra posted profits of $10.8 million, or 14¢ per share, on sales of $282.2 million for the three months ended June 30, for a bottom-line […]
Integra LifeSciences
Medtech M&A: The 10 biggest deals so far in 2017
Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions. The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions. For the medical device industry, […]
Integra LifeSciences, Johnson & Johnson pass papers on $1B Codman Neuro buy
Integra LifeSciences (NSDQ:IART) said yesterday that it passed papers with Johnson & Johnson (NYSE:JNJ) last week on its $1.05 billion cash bid for J&J’s Codman Neurosurgery unit. Completing the deal still hinges on the expiration of the Hart-Scott-Rodino waiting period and antitrust approvals in Spain and the U.K., Integra said in a regulatory filing. When it announced the deal […]
UPDATE: Integra Lifesciences shares down on Q1 release
Updated to correct the company who filed the report – previously identified Integer Holdings. Shares in Integra LifeSciences (NSDQ:IART) fell today slightly after the medical device maker posted 1st quarter earnings that met expectations on Wall Street. The Plainsboro, N.J.-based company posted profits of $6.4 million, or 8¢ per share, on sales of $258.6 million for the […]
Integra, Dr. Reddy’s ink deal for DuraGen in India
Integra LifeSciences (NSDQ:IART) and Dr. Reddy’s Laboratories (NYSE:RDY) inked an exclusive distribution agreement for the DuraGen Plus and suturable DuraGen Dural Regeneration Matrices in India. According to the deal, Dr. Reddy’s will market and distribute the medical devices throughout India. The DuraGen Plus Dural Regeneration Matrix is indicated as a dural susbtitute for the repair of […]
Integra LifeSciences slides on Q4 sales miss
Integra LifeSciences (NSDQ:IART) met the consensus earnings forecast for its 4th-quarter earnings, but saw share prices slide nevertheless after it missed Wall Street’s top-line outlook last week. The Plainsboro, N.J.-based medical device company posted profits of $28.2 million, or 35¢ per share, on sales of $255.7 million for the 3 months ended Dec. 31, for […]
Integra LifeSciences closes $200m Derma Sciences buy
Integra LifeSciences (NSDQ:IART) said today that it closed its $205 million buy of Derma Sciences (NSDQ:DSCI) and its line of wound care products. The $7-per-share deal included a line of regenerative allograft products derived from human placental tissue that Derma Sciences acquired when it paid nearly $80 million for BioD last year. Integra also agreed to pay $32 per share […]
Integra LifeSciences bids $1B for Johnson & Johnson’s Codman Neurosurgery biz
Integra LifeSciences (NSDQ:IART) said today that it’s floating a $1.05 billion cash offer for Johnson & Johnson (NYSE:JNJ) unit Codman Neurosurgery. Plainsboro, N.J.-based Integra said it plans to finance the buyout with cash on hand, a credit revolver and a new term loan; BofA Merrill Lynch and JPMorgan are backing the deal, the company said. […]
Derma Sciences pays $13m for Medihoney ahead of Integra buyout
Derma Sciences (NSDQ:DSCI) said last week that it paid $13.3 million for Medihoney, on the same day that Integra LifeSciences (NSDQ:IART) agreed to pay nearly $200 million for the tissue regeneration company. Prior to the acquisition, Derma Sciences held the exclusive global license for the Comvita-owned Medihoney brand and patents. Medihoney is eligible to receive an additional […]
Integra LifeSciences to acquire Derma Sciences for $200m
Integra LifeSciences (NSDQ:IART) said yesterday that it agreed to pay nearly $200 million for Derma Sciences (NSDQ:DSCI) and its line of wound care products. The $7-per-share deal includes a line of regenerative allograft products derived from human placental tissue that Derma Sciences acquired when it paid nearly $80 million for BioD last year. Integra also agreed to […]
Integra LifeSciences shareholders approve 2-for-1 reverse stock split
Integra LifeSciences (NSDQ:IART) said today that its shareholders have approved a 2-for-1 stock split, alongside an increase from 60 million to 240 million shares of stock. Shares are expected to be distributed by January 3, with the adjusted stock price expected to be reflected on the market the next day. The split, which will put […]